ABX464, a novel anti-inflammatory drug-candidate for the treatment of ulcerative colitis (Abivax)
Didier scherrer 1
Bruce E. Sands 2
William Sandborn 3
1 ABIVAX
2 Icahn School of Medicine at Mount Sinai
3 University of California San Diego
Session
ABX464, a novel anti-inflammatory drug-candidate for the treatment of ulcerative colitis (Abivax)
Conference
UEG Week Virtual 2021
Publisher
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]